Charles River Laboratories International (CRL) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Powered by 
Analysis
Charles River Laboratories International (CRL) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -6.41% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 25.73% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -7.33% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -26.16% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -34.42% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 35.41% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 45.04% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -12.18% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -26.16% |
| Mar 28, 2026 | -28.94% |
| Dec 27, 2025 | -51.28% |
| Sep 27, 2025 | -17.70% |
| Jun 28, 2025 | -22.09% |
| Mar 29, 2025 | -35.57% |
| Dec 28, 2024 | -52.44% |
| Sep 28, 2024 | -13.24% |
| Jun 29, 2024 | 0.03% |
| Mar 30, 2024 | 1.74% |
| Dec 30, 2023 | 9.07% |
| Sep 30, 2023 | -5.21% |
| Jul 1, 2023 | 12.76% |
| Apr 1, 2023 | 26.59% |
| Dec 31, 2022 | 32.93% |
| Sep 24, 2022 | 9.89% |
| Jun 25, 2022 | 35.68% |
| Mar 26, 2022 | 19.58% |
| Dec 25, 2021 | 32.44% |
| Sep 25, 2021 | 19.97% |